"たけだP" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonProtagonist-Takeda, Novartis post phase III wins - BioWorld MedTech
Protagonist-Takeda, Novartis post phase III wins BioWorld MedTech
Earnings Tell The Story For Takeda Pharmaceutical Company Limited (TSE:4502) - simplywall.st
Earnings Tell The Story For Takeda Pharmaceutical Company Limited (TSE:4502) simplywall.st
Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti - koreabi...
Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti koreabiomed.com
Korean drug Kecap advances toward U.S. approval, challenging Takeda's Boeqezna - CHOSUNBIZ - Chos...
Korean drug Kecap advances toward U.S. approval, challenging Takeda's Boeqezna - CHOSUNBIZ Chosun Biz
Takeda PH promotes equitable access to medicines at SEA Summit - Philippine News Agency
Takeda PH promotes equitable access to medicines at SEA Summit Philippine News Agency
Takeda taps Julie Kim as next CEO, 1st Korean American to lead global pharma company - koreabiome...
Takeda taps Julie Kim as next CEO, 1st Korean American to lead global pharma company koreabiomed.com
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide ...
ASCO25: Takeda, Protagonist make strong case for phlebotomy successor in polycythemia vera - Firs...
ASCO25: Takeda, Protagonist make strong case for phlebotomy successor in polycythemia vera FirstWord Pharma
Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India - Indian Pharma Post
Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India Indian Pharma Post
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures - BioSpace
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures BioSpace
Scoop: San Diego Biotech Partners with Takeda, Lands $1.2B Milestone Deal - Substack
Scoop: San Diego Biotech Partners with Takeda, Lands $1.2B Milestone Deal Substack
Zydus Licenses Takeda's GERD Drug Vonoprazan for India - Rediff MoneyWiz
Zydus Licenses Takeda's GERD Drug Vonoprazan for India Rediff MoneyWiz
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data d...
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail Fierce Biotech
Changes of farnesoid X receptor and Takeda G‑protein coupled receptor 5 following biliary tract e...
Changes of farnesoid X receptor and Takeda G‑protein coupled receptor 5 following biliary tract external drainage in hemorrhagic shock Spandidos Publications
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? - Nasdaq
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? Nasdaq
Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India - Business Standard
Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India Business Standard
Lymphocytopenia following adjuvant radiotherapy for breast cancer - Takeda - 2024 - Precision Rad...
Lymphocytopenia following adjuvant radiotherapy for breast cancer - Takeda - 2024 - Precision Radiation Oncology Wiley Online Library
Zydus ties with Takeda to sell GERD drug - Mint
Takeda’s market exit and return of vonoprazan raise stakes in Korea’s drug pricing battle - korea...
Takeda’s market exit and return of vonoprazan raise stakes in Korea’s drug pricing battle koreabiomed.com
Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndro...
Neurocrine’s Takeda-Partnered Drug Candidate Aces Phase II Depression Study - BioSpace
Neurocrine’s Takeda-Partnered Drug Candidate Aces Phase II Depression Study BioSpace
Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dre...
Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dream Fierce Biotech
Takeda, Protagonist unveil plenary data for potential blockbuster rare blood disease drug - Endpo...
Takeda, Protagonist unveil plenary data for potential blockbuster rare blood disease drug Endpoints News
Takeda’s Oral Orexin Agonist to Enter Phase 3 Trials in Narcolepsy Type 1 - Sleep Review
Takeda’s Oral Orexin Agonist to Enter Phase 3 Trials in Narcolepsy Type 1 Sleep Review
Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another - BioSpace
Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another BioSpace
Takeda, Protagonist Therapeutics Agree to Global Collaboration on Late-Stage Polycythemia Vera Tr...
Takeda, Protagonist Therapeutics Agree to Global Collaboration on Late-Stage Polycythemia Vera Treatment Pharmaceutical Executive
Takeda Korea names Peter Trang as head of business operations - koreabiomed.com
Takeda Korea names Peter Trang as head of business operations koreabiomed.com
Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in ...
Zydus announces non-exclusive patent licensing agreement with Takeda for ‘Vault’ (Vonoprazan) in India Express Pharma
Mankind Pharma inks pact with Takeda to commercialise acidity drug in India - Business Standard
Mankind Pharma inks pact with Takeda to commercialise acidity drug in India Business Standard
How To Clear Takeda Castle In Assassin's Creed Shadows - TheGamer
How To Clear Takeda Castle In Assassin's Creed Shadows TheGamer
Torrent Pharma in pact with Takeda to commercialize acid reflux drug - Mint
Torrent Pharma in pact with Takeda to commercialize acid reflux drug Mint
Torrent inks licensing agreement with Takeda to commercialize its novel gastrointestinal drug in ...
Torrent inks licensing agreement with Takeda to commercialize its novel gastrointestinal drug in India Indian Pharma Post
Torrent Pharma, Takeda to commercialise GI drug in India - Times of India
Torrent Pharma, Takeda to commercialise GI drug in India Times of India
Torrent Pharma Licenses Vonoprazan GERD Drug from Takeda - Rediff MoneyWiz
Torrent Pharma Licenses Vonoprazan GERD Drug from Takeda Rediff MoneyWiz
Transition‐Metal‐Free Cross‐Coupling by Using Tertiary Benzylic Organoboronates - Wiley Online Li...
Transition‐Metal‐Free Cross‐Coupling by Using Tertiary Benzylic Organoboronates Wiley Online Library
Zydus to market Takeda’s gastro drug - Times of India
Zydus to market Takeda’s gastro drug Times of India
Host–microbiota interactions in rheumatoid arthritis - Nature
Torrent Pharmaceuticals enters into patent licensing agreement with Takeda - Business Standard
Torrent Pharmaceuticals enters into patent licensing agreement with Takeda Business Standard
Zydus announces licensing deal with Takeda for new GERD drug Vault - Business Standard
Zydus announces licensing deal with Takeda for new GERD drug Vault Business Standard
Takeda Pharmaceutical names Serina Fischer as head of India operations - ETHRWorld.com
Takeda Pharmaceutical names Serina Fischer as head of India operations ETHRWorld.com
Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India - ET HealthWorld
Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India ET HealthWorld
Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in Ind...
Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India Express Pharma
Takeda, Frazier Healthcare Partners to launch Phathom Pharma - BioSpectrum Asia
Takeda, Frazier Healthcare Partners to launch Phathom Pharma BioSpectrum Asia
Cipla signs agreement with Takeda to commercialise Vonoprazan - Express Pharma
Cipla signs agreement with Takeda to commercialise Vonoprazan Express Pharma
Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in Indi...
Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in India financialexpress.com
Fig. 2 Cervical myoma. (Reproduced with permission from Takeda S.... - researchgate.net
Fig. 2 Cervical myoma. (Reproduced with permission from Takeda S.... researchgate.net
Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Can...